30.07.2024CordenPharma is making a record investment of ~€900m over the next 3 years in expanding our peptide platform, both at our CordenPharma Colorado, US site and in Europe. The expansions...
31.07.2024CordenPharma is making a record investment of ~€900m over the next 3 years in expanding our peptide platform, both at our CordenPharma Colorado, US site and in Europe. The expansions...
01.08.2024New facility in San Diego will support continued development of Vividion’s global discovery and clinical portfolio and pave the way for future programs aimed at bringing first-in-class therapeutics to patients in need
01.08.2024New facility in San Diego will support continued development of Vividion’s global discovery and clinical portfolio and pave the way for future programs aimed at bringing first-in-class therapeutics to patients in need
30.07.2024Die EyeC GmbH, ein weltweit tätiger Anbieter von automatisierten Druckbildinspektionssystemen, gibt seine Zusammenarbeit...
26.07.2024The Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at the Lonza Group Annual General Meeting (AGM) in May 2025.
01.08.2024The Lonza Board of Directors announced the nomination of Juan Andres and Eric Drapé as Independent Members of the Board. The Board will propose to shareholders the election of both nominees at the Lonza Group Annual General Meeting (AGM) in May 2025.
01.08.2024Merck hat eine Vereinbarung zum Verkauf des Surface-Solutions-Geschäfts für 665 Mio. € in bar an Global New Material International unterzeichnet.
26.07.2024Merck hat eine Vereinbarung zum Verkauf des Surface-Solutions-Geschäfts für 665 Mio. € in bar an Global New Material International unterzeichnet.
30.07.2024Merck hat eine Vereinbarung zum Verkauf des Surface-Solutions-Geschäfts für 665 Mio. € in bar an Global New Material International unterzeichnet.
Sie sehen Artikel 18601 bis 18610 von insgesamt 19140